Patent Assignment
Reel/Frame 038330/0382
Release of Security Interest
Recorded: 2016-04-01
Pages: 6
Assignor
OXFORD FINANCE LLC, AS COLLATERAL AGENT
Executed: 2016-03-31
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(18)
Therapeutic Combinations Comprising (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Methods of Using Sns-595
Pharmaceutical Compositions of (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
Application:
11/890,196 →
Publication:
US 2008/0063642
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Cancer
1,8-Naphthyridine Compounds for the Treatment of Cancer
Pharmaceutical Dosage Forms for (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid
Application:
12/376,118 →
Publication:
US 2010/0048609
Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid in Combination Therapy
Methods of Using (+)-1,4-Dihydro-7-[(3S,4S)-3-Methoxy-4-(Methylamino)-1-Pyrrolidinyl]-4-Oxo-1-(2-Thiazolyl)-1,8-Naphthyridine-3-Carboxylic Acid for Treatment of Antecedent Hematologic Disorders
Application:
12/747,167 →
Publication:
US 2011/0008371
Stable SNS-595 Compositions and Methods of Preparation
Compounds and Methods for Treatment of Cancer
Stable Sns-595 Compositions and Methods of Preparation
Sns-595 and Methods of Using the Same
Application:
13/095,111 →
Publication:
US 2011/0263524
Sns-595 and Methods of Using the Same
Methods of Using Sns-595 for Treatment of Cancer Subjects with Reduced BRCA2 Activity
Application:
13/203,718 →
Publication:
US 2012/0148564
1,8-Naphthyridine Compounds for the Treatment of Cancer
SNS-595 and methods of using the same
Application:
60/921,500 →
Publication:
US 2006/0025437
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 14, 2005
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 016383/0541 →
Assignment of Assignor's Interest
Jun 14, 2005
From: ARKIN, MICHELLE; HYDE, JENNIFER; WALKER, DUNCAN; WRIGHT, JASMIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 016706/0201 →
Assignment of Assignor's Interest
Aug 16, 2006
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 018122/0933 →
Assignment of Assignor's Interest
Nov 9, 2007
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.; MICHELSON, GLENN; SCATENA, CAROLINE DARNE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 020091/0039 →
Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 020091 Frame 0039. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest..
Feb 21, 2008
From: ADELMAN, DANIEL C.; SILVERMAN, JEFFREY A.; MICHELSON, GLEN; SCATENA, CAROLINE DARNE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 020542/0441 →
Assignment of Assignor's Interest
Feb 5, 2009
From: ADELMAN, DANIEL C.; EVANCHIK, MARC J.; SUDHAKAR, ANANTHA; JACOBS, JEFFREY WILLIAM
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 022212/0660 →
Assignment of Assignor's Interest
Jun 18, 2009
From: ADELMAN, DANIEL C.; HYDE, JENNIFER; SILVERMAN, JEFFREY A.; ARKIN, MICHELLE
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 022847/0225 →
Assignment of Assignor's Interest
Oct 27, 2009
From: JACOBS, JEFFREY W.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 023431/0975 →
Assignment of Assignor's Interest
Nov 6, 2009
From: WALKER, DUNCAN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 023481/0296 →
Assignment of Assignor's Interest
Feb 16, 2010
From: SUDHAKAR, ANANTHA
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024001/0591 →
Assignment of Assignor's Interest
Apr 12, 2010
From: SYNGENE INTERNATIONAL LTD.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024219/0096 →
Assignment of Assignor's Interest
Apr 12, 2010
From: SUBRAMANI, TAMILARASAN; RAHUMAN, MOHAMED SHEIK MOHAMED MUJEEBUR; SUBBIAH, RAMAR
To: SYNGENE INTERNATIONAL LTD.
Reel/Frame 024216/0165 →
Assignment of Assignor's Interest
Aug 18, 2010
From: SILVERMAN, JEFFREY A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024856/0449 →
Assignment of Assignor's Interest
Sep 2, 2010
From: MICHELSON, GLENN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 024934/0768 →
Assignment of Assignor's Interest
Dec 16, 2010
From: SUDHAKAR, ANANTHA
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025510/0011 →
Assignment of Assignor's Interest
Dec 17, 2010
From: SUDHAKAR, ANANTHA; JACOBS, JEFF; HASHASH, AHMAD; RITCHIE, SEAN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025520/0455 →
Assignment of Assignor's Interest
Dec 5, 2011
From: HAWTIN, RACHAEL E.; FOX, JUDITH A.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 027328/0209 →
Security Agreement
May 7, 2012
From: SUNESIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 028169/0528 →
Assignment of Assignor's Interest
Jun 24, 2013
From: HIGAKI, MASARU; NAKAO, SATOSHI
To: DAINIPPON SUMITOMO PHARMA CO., LTD.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 030672/0088 →
Security Interest
May 10, 2016
From: SUNESIS PHARMACEUTICALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 038655/0493 →
Change of Name
Sep 1, 2016
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 039901/0249 →
Release of Security Interest
Nov 5, 2020
From: WESTERN ALLIANCE BANK
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 054335/0429 →